Pharmacological preconditioning of ischemic heart disease by low-dose dipyridamole

Int J Cardiol. 1996 Sep;56(1):17-27. doi: 10.1016/0167-5273(96)02712-x.

Abstract

Fourteen patients affected with coronary artery disease underwent two consecutive dipyridamole echocardiographic stress tests, in basal conditions and after repeated low doses of intravenous dipyridamole, following the observation that pulse increases in adenosine plasma levels due to repeated intravenous administration of dipyridamole mimic the mechanism of ischemic preconditioning. Echocardiographic, electrocardiographic, haemodynamic parameters, and adenosine plasma levels were measured. After the second test, six patients were completely negative, and in those eight still positive the onset of dyssynergy was delayed.

MeSH terms

  • Aged
  • Chest Pain / etiology
  • Coronary Disease / diagnostic imaging
  • Coronary Disease / drug therapy*
  • Coronary Disease / physiopathology
  • Dipyridamole / administration & dosage*
  • Dose-Response Relationship, Drug
  • Echocardiography
  • Electrocardiography
  • Exercise Test
  • Female
  • Hemodynamics / drug effects
  • Humans
  • Incidence
  • Infusions, Intravenous
  • Ischemic Preconditioning, Myocardial / methods*
  • Male
  • Reproducibility of Results
  • Vasodilator Agents / administration & dosage*

Substances

  • Vasodilator Agents
  • Dipyridamole